89 related articles for article (PubMed ID: 1843882)
41. [Microbiological studies in the treatment of peritonitis].
Fedorov VD; Lizgunova AV; Nikitin AM
Khirurgiia (Mosk); 1971 Jan; 47(1):52-60. PubMed ID: 4930586
[No Abstract] [Full Text] [Related]
42. An open randomised comparison of ofloxacin and doxycycline in lower respiratory tract infections.
Harazim H; Wimmer J; Mittermayer HP
Drugs; 1987; 34 Suppl 1():71-3. PubMed ID: 3481331
[TBL] [Abstract][Full Text] [Related]
43. Antimicrobial efficacy of erythromycin stearate. A report from the general Practitioner Research Group.
Practitioner; 1974 Jan; 212(267):120-2. PubMed ID: 4591200
[No Abstract] [Full Text] [Related]
44. [Quality control of antimicrobial susceptibility testing by disk diffusion test].
Ma Y; Li JY; Jin SH
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):355-6. PubMed ID: 15558846
[No Abstract] [Full Text] [Related]
45. Ofloxacin in lower respiratory tract infections.
Petermann W
Infection; 1991; 19 Suppl 7():S372-7. PubMed ID: 1804786
[TBL] [Abstract][Full Text] [Related]
46. Oral ofloxacin for infections caused by bacteria resistant to oral antimicrobial agents.
Eron LJ; Gentry LO
Diagn Microbiol Infect Dis; 1992 Jul; 15(5):435-9. PubMed ID: 1643820
[TBL] [Abstract][Full Text] [Related]
47. [Digestive tract as the main endogenous source of bacterial and fungal infections. The importance of maintaining colonization resistance].
van der Waaij D,
Antibiot Khimioter; 1992 Jun; 37(6):36-41. PubMed ID: 1417343
[No Abstract] [Full Text] [Related]
48. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis.
Reacher MH; Shah A; Livermore DM; Wale MC; Graham C; Johnson AP; Heine H; Monnickendam MA; Barker KF; James D; George RC
BMJ; 2000 Jan; 320(7229):213-6. PubMed ID: 10642227
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of oral administration of ofloxacin in lower respiratory tract infections in aged patients with chronic lung disease.
Yamaoka M; Fukuchi Y; Yokouchi M; Teramoto N; Nagase T; Ishida K; Ohtomo E; Orimo H
Chemotherapy; 1991; 37 Suppl 1():14-8. PubMed ID: 2049960
[TBL] [Abstract][Full Text] [Related]
50. [Clinical trials of ofloxacin in sequential use (intravenous and oral) in patients with serious hospital infection].
Iakovlev SV; Dvoretskiĭ LI; Shakhova TV; Kudinkina IP; Vorob'ev PA; Vlasenko NA; Prokhorenko TS; Eremina LV
Antibiot Khimioter; 1996; 41(9):53-6. PubMed ID: 9005788
[TBL] [Abstract][Full Text] [Related]
51. Clinical evaluation of ofloxacin in lower respiratory tract infections.
Kobayashi H
Infection; 1986; 14 Suppl 4():S279-82. PubMed ID: 3469163
[TBL] [Abstract][Full Text] [Related]
52. [The clinical observation of China-made ofloxacin eye drops in the treatment of bacterial infection of the external eye].
Lin B; Su X
Yan Ke Xue Bao; 1994 Dec; 10(4):251-3. PubMed ID: 7774703
[TBL] [Abstract][Full Text] [Related]
53. [Clinical studies on the utility of ofloxacin for lower respiratory infections].
Sawae Y; Kashiwagi S; Kumagai Y; Ishimaru T; Takii M; Shigeoka H; Kuwabara K; Takita A; Muranishi T; Nagafuchi S
Jpn J Antibiot; 1991 Jan; 44(1):48-57. PubMed ID: 2041147
[TBL] [Abstract][Full Text] [Related]
54. Daily single-dose regimen and alternate-two-week triple-dose/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections.
Watanabe A; Oizumi K; Motomiya M; Nukiwa T
Tohoku J Exp Med; 1995 May; 176(1):25-33. PubMed ID: 7482516
[TBL] [Abstract][Full Text] [Related]
55. Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease.
Watanabe A
Infection; 1991; 19 Suppl 7():S384-7. PubMed ID: 1804788
[TBL] [Abstract][Full Text] [Related]
56. [RESULTS OF THE TREATMENT OF PATIENTS WITH CHRONIC INFLAMMATORY BRONCHOPULMONARY PROCESSES IN RELATION TO SENSITIVITY OF THE MICROFLORA TO ANTIBIOTICS].
DUBILEI VV
Antibiotiki; 1963 Aug; 8():746-50. PubMed ID: 14124734
[No Abstract] [Full Text] [Related]
57. Once-daily use of ofloxacin for prophylaxis in breast cancer surgery.
Morimoto K; Kinoshita H
Chemotherapy; 1998; 44(2):135-41. PubMed ID: 9551245
[TBL] [Abstract][Full Text] [Related]
58. Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.
Vieler E; Jantos C; Schmidts HL; Weidner W; Schiefer HG
Antimicrob Agents Chemother; 1993 Apr; 37(4):846-50. PubMed ID: 8494382
[TBL] [Abstract][Full Text] [Related]
59. [Clinical evaluation of clindamycin-2-phosphate in infectious diseases (author's transl)].
Fujimori I; Shimada S; Koizumi H
Jpn J Antibiot; 1977 Jan; 30(1):39-41. PubMed ID: 320361
[TBL] [Abstract][Full Text] [Related]
60. Oral ofloxacin for the treatment of acute bacterial pneumonia: use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial.
Sanders WE; Morris JF; Alessi P; Makris AT; McCloskey RV; Trenholme GM; Iannini P; Bittner MJ
Am J Med; 1991 Sep; 91(3):261-6. PubMed ID: 1892146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
